Synergistic antitumor effects of circularly permuted TRAIL with doxorubicin in triple-negative breast cancer: Circularly permuted TRAIL with Dox in TNBC

Circularly permuted TRAIL (CPT), a novel recombinant TRAIL mutant, is a potent antitumor agent. However, its efficacy in triple-negative breast cancer (TNBC) remains unclear. Treatment with CPT alone and in combination with doxorubicin (Dox) is explored for its effects on the proliferation and apopt...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jia, Zhu, Tienian, Liu, Jiankun, Cui, Yujie, Yang, Shifang, Zhao, Ruijing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449636/
https://www.ncbi.nlm.nih.gov/pubmed/37559457
http://dx.doi.org/10.3724/abbs.2023160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449636/
https://www.ncbi.nlm.nih.gov/pubmed/37559457
http://dx.doi.org/10.3724/abbs.2023160

Ejemplares similares